Results 181 to 190 of about 397,094 (306)

Summary of the Clinical Practice Guidelines for Male Infertility by the Japanese Urological Association With the Support of the Japan Society for Reproductive Medicine [PDF]

Akira Tsujimura, Masashi Iijima, Yukihiro Umemoto, Hideyuki Kobayashi, Akira Komiya, Koji Shiraishi, Koji Chiba, Yasushi Hirota, Shinichiro Fukuhara, Yasushi Yumura   +9 more
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Addressing the consequences of the corporatization of reproductive medicine. [PDF]

Med Law Rev
Attinger SA, Jackson E, Karpin I, Kerridge I, Newson AJ, Stewart C, van de Wiel L, Lipworth W.   +7 more
europepmc   +1 more source

AYURVEDIC MANAGEMENT OF INFERTILITY: EVIDENCE-BASED UPDATES FOR INTEGRATIVE REPRODUCTIVE MEDICINE

Devendra Singh Rawat, Dr Hemant Kumar, Deeksha Kumari   +2 more
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Infections of chlamydia trachomatis, mycoplasma genitalium and neisseria gonorrhoeae among the outpatients of reproductive medicine center in Chongqing, China: a retrospective study. [PDF]

BMC Infect Dis
Luo X, Chen X, Liang Y, Chen W, Huang G, Xiang Y, Chen K.   +6 more
europepmc   +1 more source

Assisted reproductive technology in reproductive medicine — possibilities and limitations

, 2016
Szamatowicz Marian
openalex   +2 more sources

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

The challenges of achieving patient satisfaction in the field of reproductive medicine. [PDF]

F S Rep
Brezina PR.
europepmc   +1 more source

Reply to: “Implications of mycophenolate mofetil in a reproductive age patient cohort: Maternal fetal medicine point of view” [PDF]

Charlotte D. Slooter, Anna Stoelinga, Romée J.A.L.M. Snijders   +2 more
openalex   +1 more source